Jerry D Brewer1, Tait D Shanafelt2, Farzaneh Khezri3, Ivette M Sosa Seda3, Adeel S Zubair4, Christian L Baum3, Christopher J Arpey3, James R Cerhan5, Timothy G Call6, Randall K Roenigk3, Carin Y Smith7, Amy L Weaver7, Clark C Otley3. 1. Department of Dermatology, Mayo Clinic, Rochester, Minnesota. Electronic address: brewer.jerry@mayo.edu. 2. Division of Hematology, Mayo Clinic, Rochester, Minnesota. 3. Department of Dermatology, Mayo Clinic, Rochester, Minnesota. 4. Mayo Medical School, Mayo Clinic College of Medicine, Rochester, Minnesota. 5. Division of Epidemiology, Mayo Clinic, Rochester, Minnesota. 6. Division of Hematology, Mayo Clinic, Rochester, Minnesota; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. 7. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND: Cutaneous malignancy is associated with worse outcomes in patients with chronic lymphocytic leukemia (CLL). OBJECTIVE: We sought to identify the incidence and recurrence rate of nonmelanoma skin cancer (NMSC) in patients with non-Hodgkin lymphoma (NHL). METHODS: NMSC incidence was calculated and Cox proportional hazards models were used to evaluate associations with risk of recurrence for patients with NHL between 1976 and 2005 who were in the Rochester Epidemiology Project research infrastructure. RESULTS: We identified 282 patients with CLL or small lymphocytic lymphoma and 435 with non-CLL NHL. The incidence of basal cell carcinoma and squamous cell carcinoma was 1829.3 (95% confidence interval [CI] 1306.7-2491.1) and 2224.9 (95% CI 1645.9-2941.6), respectively, in patients with CLL. The cumulative recurrence rate at 8 years after treatment with Mohs micrographic surgery was 8.3% (95% CI 0.0%-22.7%) for basal cell carcinoma and 13.4% (95% CI 0.0%-25.5%) for squamous cell carcinoma in patients with CLL. LIMITATIONS: This was a retrospective cohort study. CONCLUSIONS: After Mohs micrographic surgery and standard excision of NMSC, patients with NHL had a skin cancer recurrence rate that was higher than expected. Careful treatment and monitoring of patients with NHL and NMSC are warranted.
BACKGROUND:Cutaneous malignancy is associated with worse outcomes in patients with chronic lymphocytic leukemia (CLL). OBJECTIVE: We sought to identify the incidence and recurrence rate of nonmelanoma skin cancer (NMSC) in patients with non-Hodgkin lymphoma (NHL). METHODS: NMSC incidence was calculated and Cox proportional hazards models were used to evaluate associations with risk of recurrence for patients with NHL between 1976 and 2005 who were in the Rochester Epidemiology Project research infrastructure. RESULTS: We identified 282 patients with CLL or small lymphocytic lymphoma and 435 with non-CLL NHL. The incidence of basal cell carcinoma and squamous cell carcinoma was 1829.3 (95% confidence interval [CI] 1306.7-2491.1) and 2224.9 (95% CI 1645.9-2941.6), respectively, in patients with CLL. The cumulative recurrence rate at 8 years after treatment with Mohs micrographic surgery was 8.3% (95% CI 0.0%-22.7%) for basal cell carcinoma and 13.4% (95% CI 0.0%-25.5%) for squamous cell carcinoma in patients with CLL. LIMITATIONS: This was a retrospective cohort study. CONCLUSIONS: After Mohs micrographic surgery and standard excision of NMSC, patients with NHL had a skin cancer recurrence rate that was higher than expected. Careful treatment and monitoring of patients with NHL and NMSC are warranted.
Authors: L B Travis; R E Curtis; B Glimelius; E Holowaty; F E Van Leeuwen; C F Lynch; J Adami; M Gospodarowicz; S Wacholder; P Inskip Journal: J Natl Cancer Inst Date: 1993-12-01 Impact factor: 13.506
Authors: Khosrow Mehrany; David R Byrd; Randall K Roenigk; Roger H Weenig; P Kim Phillips; Tri H Nguyen; Clark C Otley Journal: Dermatol Surg Date: 2003-02 Impact factor: 3.398
Authors: Apostolia-Maria Tsimberidou; Sijin Wen; Peter McLaughlin; Susan O'Brien; William G Wierda; Susan Lerner; Sara Strom; Emil J Freireich; L Jeffrey Medeiros; Hagop M Kantarjian; Michael J Keating Journal: J Clin Oncol Date: 2008-12-29 Impact factor: 44.544
Authors: Geffen Kleinstern; Abdul Rishi; Sara J Achenbach; Kari G Rabe; Neil E Kay; Tait D Shanafelt; Wei Ding; Joe F Leis; Aaron D Norman; Timothy G Call; James R Cerhan; Sameer A Parikh; Christian L Baum; Susan L Slager Journal: J Am Acad Dermatol Date: 2020-07-16 Impact factor: 11.527
Authors: Manette A W Dinnessen; Otto Visser; Sanne H Tonino; Marjolein W M van der Poel; Nicole M A Blijlevens; Marie José Kersten; Pieternella J Lugtenburg; Avinash G Dinmohamed Journal: EJHaem Date: 2020-10-08
Authors: Elena Campione; Monia Di Prete; Ilaria Del Principe; Laura Diluvio; Luigi Citarella; Augusto Orlandi; Sergio Chimenti; Luca Bianchi Journal: J Med Case Rep Date: 2016-03-11